Skip to content

13F-HR filed by BOONE CAPITAL MANAGEMENT LLC

BOONE CAPITAL MANAGEMENT LLC filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-14, with 13 holding rows worth $278,589,927.

Accession
0001214659-23-011278
Filed
2023-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2023

A holdings report, 13 entries on the cover page, a total value of $278,589,927 stated on the cover page (in dollars after the unit check, H1), rows summing to $278,589,927 with VALUE read as dollars as filed, 13F file number 028-23055. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
UNUM GROUP COM91529Y106Stock857,565$40,905,851dollars as filed
MOLINA HEALTHCARE INC60855R100COM106,519$32,087,784dollars as filed
BAXTER INTL INC071813109COM687,701$31,331,658dollars as filed
Cigna Corporation125523100COM110,551$31,020,611dollars as filed
ENOVIS CORPORATION194014502COM427,793$27,430,087dollars as filed
Danaher Corporation235851102COM109,910$26,378,400dollars as filed
Amgen Inc.031162100COM83,499$18,538,448dollars as filed
BIOGEN INC COM09062X103Stock62,877$17,910,513dollars as filed
AbbVie,Inc.00287Y109COM88,026$11,859,743dollars as filed
IDEAYA BIOSCIENCES INC COM45166A102Stock496,433$11,666,176dollars as filed
QUANTERIX CORP74766Q101COMMON STOCK501,144$11,300,797dollars as filed
CEREVEL THERAPEUTICS HLDNG I15678U128COM300,000$9,537,000dollars as filed
TRUBRIDGE INC205306103COM349,245$8,622,859dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001214659-23-011278this filing2023-08-14acceptance time not in the bulk data set